“…With relatively little data processing required, and the ability to extract features and characteristics without prior knowledge of biology, chemistry or medicine, advances can be made in areas where physicians currently struggle, such as determining if novel variants in a patient's genome are medically relevant, whether abnormalities in plasma could be early-onset cancerous mutations, or how cell features are linked to tumour pathology [89,90]. Medical imaging is often at the forefront in integrating AI, as it is a field of complex and ambiguous data, which often requires lengthy manual processing, where an expert will medically interpret and analyse, and then annotate, large amounts of data [91,92]. While ConvNets and deep learning have traditionally been utilised effectively in segmentation of tissues and organs, increasingly more complex tasks are being advanced through deep learning, such as detection of abnormalities or non-invasive cell counting, morphological identification and behavioural prediction, including with stem cells [35,87,[93][94][95][96][97][98][99].…”